
Biogen BIIB
€ 161.89
-1.08%
Geschäftsbericht 2025
hinzugefügt 06.02.2026
Biogen PEG 2011-2026 | BIIB
PEG Jährlich Biogen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.62 | -1.57 | -1.63 | -1.84 | -2.7 | -1.6 | 0.194 | 0.187 | -0.997 | 1.58 | 0.745 | 0.54 | 1.14 | 1.92 | 0.821 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.92 | -2.7 | -0.106 |
PEG anderer Aktien in der Pharmaeinzelhändler
| Name | PEG | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
AbCellera Biologics
ABCL
|
0.0142 | $ 3.58 | -1.38 % | $ 1.07 B | ||
|
Acer Therapeutics
ACER
|
0.0443 | - | 2.71 % | $ 14 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
ADMA Biologics
ADMA
|
0.937 | $ 15.57 | -5.89 % | $ 3.71 B | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | ||
|
Aptorum Group Limited
APM
|
0.0951 | $ 0.82 | -0.73 % | $ 4.47 M | ||
|
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | ||
|
Alpine Immune Sciences
ALPN
|
4.18 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.000293 | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Anika Therapeutics
ANIK
|
-0.431 | $ 14.19 | -1.18 % | $ 208 M | ||
|
ANI Pharmaceuticals
ANIP
|
-1.07 | $ 75.6 | -1.22 % | $ 1.46 B | ||
|
Apellis Pharmaceuticals
APLS
|
-5.4 | $ 20.24 | 1.91 % | $ 2.55 B | ||
|
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
0.0342 | - | -13.39 % | $ 1.45 M | ||
|
ARCA biopharma
ABIO
|
-0.0372 | - | 1052.0 % | $ 415 M | ||
|
Athersys
ATHX
|
0.0584 | - | 3.77 % | $ 22.4 M | ||
|
Autolus Therapeutics plc
AUTL
|
0.0906 | $ 1.5 | -8.28 % | $ 383 M | ||
|
AVEO Pharmaceuticals
AVEO
|
-0.00128 | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
-5.2 | $ 159.87 | -2.57 % | $ 7.95 B | ||
|
BridgeBio Pharma
BBIO
|
0.28 | $ 65.73 | -1.22 % | $ 12.6 B | ||
|
Acasti Pharma
ACST
|
-0.0483 | - | 4.01 % | $ 150 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.00304 | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
0.69 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B | ||
|
Bellerophon Therapeutics
BLPH
|
0.0308 | - | -74.18 % | $ 955 K | ||
|
Bellicum Pharmaceuticals
BLCM
|
0.000006 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
0.863 | - | -7.31 % | $ 87 M | ||
|
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | ||
|
BioLineRx Ltd.
BLRX
|
1.32 | $ 2.72 | -3.31 % | $ 908 M | ||
|
BioMarin Pharmaceutical
BMRN
|
0.177 | $ 60.54 | 0.18 % | $ 11.6 B | ||
|
Burford Capital Limited
BUR
|
-0.568 | $ 8.26 | -1.31 % | $ 1.36 B | ||
|
CymaBay Therapeutics
CBAY
|
-24.1 | - | - | $ 3.45 B | ||
|
Codexis
CDXS
|
-0.0807 | $ 1.25 | 16.2 % | $ 91.8 M | ||
|
Cabaletta Bio
CABA
|
-0.00014 | $ 3.2 | -6.71 % | $ 3.74 M | ||
|
Coherus BioSciences
CHRS
|
0.0108 | $ 1.76 | -0.28 % | $ 166 M | ||
|
Checkpoint Therapeutics
CKPT
|
-0.00928 | - | - | $ 169 M | ||
|
Clovis Oncology
CLVS
|
0.0458 | - | -7.23 % | $ 13 M |